Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Connell W and Miller A, “Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy,” Drug Safety , 1999, 21(4):311-23. [PubMed 10514022 ] Diav-Citrin O, Park YH, Veerasuntharam G, et al, “The Safety of Mesalamine in Human Pregnancy: A Prospective Controlled Cohort Study,” Gastroenterology , 1998, 114(1):23-8. [PubMed 9428214 ] Dubinsky M, Abraham B, and Mahadevan U, “Management of the Pregnant IBD Patient,” Inflamm Bowel Dis , 2008, 14(12):1736-50. [PubMed 18626967 ] Quiros JA, Heyman MB, Pohl JF, et al, "Safety, Efficacy, and Pharmacokinetics of Balsalazide in Pediatric Patients With Mild-to-Moderate Active Ulcerative Colitis: Results of a Randomized, Double-Blind Study," J Pediatr Gastroenterol Nutr , 2009, 49(5):571-9. [PubMed 19633577 ] Scherl EJ, Pruitt R, Gordon GL, et al, "Safety and Efficacy of a New 3.3 g b.i.d. Tablet Formulation in Patients With Mild-to-Moderately-Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study," Am J Gastroenterol , 2009, 104(6):1452-9. [PubMed 19491859 ] Topic 13082 Version 36.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0504-118.195.65.248-E943584887-S244013.14]